Feb 17, 2023
Professor Arik Eisenkraft is the VP of Clinical and Regulation at Biobeat, which has developed a short-term disposable chest patch that collects and transmits vital signs data to a cloud-based platform. They have also developed a rechargeable wrist device that collects the same kind of data and is designed for long-term use at home, in care centers, or for clinical trials. Using the optical technique photoplethysmography, they collect reflected light from the tissue not using the light that goes through the tissue, allowing for these form factors.
Arik explains, “I can tell you that specifically at Biobeat, we had several very exciting clinical studies in which, for example, we managed to show that we can detect unique patterns of flu two days before people started to feel ill. That's amazing because now it can help you direct treatments or use all kinds of measures like isolation, as we saw early in the COVID pandemic.”
“Biobeat is using an optical method, photoplethysmography, or PPG, which is widely used in all the past oximeters. I think that everyone now knows that because of COVID. We developed our own in-house sensor and the algorithms that are related to it. With most devices, you can measure pulse and blood oxygen saturation.”
“With our device, we get a much stronger and clean signal. And by that, we can now track not only these two parameters but actually a total of 13 different parameters, including cuffless blood pressure, cardiac output, stroke volume, respiratory rate, temperature, all the five basic parameters that nurses have to collect wherever the patient is, whether in the hospital or the clinic or at home.”
@BiobeatT #RemotePatientMonitoring #RPM #MedicalDevice #Wearables #AI #Cardio #Noninvasive #HospitalatHome #DigitalHealth #Telemedicine #Healthcare #Medtech #PatientExperience #BloodPressure #CardiacOutput #StrokeVolume #HealthcareInnovation #Health #PersonalizedMedicine #PrecisionMedicine